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Summary The effects of N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) and 1-(5-isoquinoline-
sulfonyl)-2-methylpiperazine (H-7) on the growth of P388 and its multidrug-resistant (MDR) variants were
examined with the objective of assessing the possible changes in cyclic nucleotide-dependent protein kinases
and protein kinase C-mediated pathways associated with MDR. H-8, an inhibitor of cyclic neuclotide-
dependent protein kinases, inhibited the growth of the parental P388 murine leukaemic cells, but not that of
MDR variants up to 200ylM. However the growth of both drug-sensitive and resistant cell lines were
uniformly inhibited by H-7. Both the cytotoxic and cytokinetic results revealed that the growth-inhibition by
H-8 of P388 cells is mainly due to a blockade ofcell-cycle progression rather than due to a killing of cells. The
degree of resistance to H-8 was directly proportional to their extent of resistance to vincristine, adriamycin,
and 4'-demethylepipodophyllotoxin-9-(4,6-0-ethylidene)-p-D-glucopyranoside (VP-16) and to that of the
expression of P-glycoprotein. These findings raised the possibility that P-glycoprotein might play a role in the
cross-resistance to H-8. To test the hypothesis, we examined the effect of H-8 on the binding of 3H-vincristine
to membrane fraction isolated from P388/VCR-600 cells and on the enhancement ofcytotoxicity to anticancer
drugs in MDR cells. H-8 did not have any influences on these reactions. Thus, the cross-resistance to H-8 may
be mediated through a mechanism different from an overexpression of P-glycoprotein. Although cyclic AMP
dependent protein kinase (A-kinase) activity was 1.77-fold increased in P388/VCR-600 cells, H-8 inhibited
A-kinase activity of both P388/VCR-600 and P388 cells in a similar rate. There was no detectable cyclic GMP
dependent protein kinase activity in these cell lines. These data suggest that the differential effect of H-8 on the
proliferation of these cell lines may be mediated through an inhibition of one or more targets other than these
protein kinases.
Multidrug resistance (MDR) is frequently characterised by
diminished drug accumulation in resistant cells compared to
their drug-sensitive parental cells (Inaba & Johnson, 1977;
Tsuruo et al., 1982). Concomitant overexpression of a 150-
180 kDa surface membrane glycoprotein (P-glycoprotein)
usually correlates with MDR (Juliano & Ling, 1976; Beck et
al., 1979; Safa et al., 1986; Cornwell et al., 1986). Cells
selected in vitro with MDR phenotype are also reported to be
significantly altered in their growth characteristics such as
tumorigenicity and metastatic potential (Biedler et al., 1975;
Mirski et al., 1987). Although MDR is associated with a
change in the expression of epidermal growth factor receptor
(Zuckier & Tritton, 1983; Meyers et al., 1986; Vickers et al.,
1988) and in several enzyme activities (Batist et al., 1986;
Deffie et al., 1988), biochemical and molecular bases of the
change in the growth characteristics associated with MDR
are not clearly established.
Although the molecular function of P-glycoprotein is not
fully understood, an increasing body of evidence suggests
that P-glycoprotein is a binding protein for chemotherapeutic
agents such as vinblastine (Cornwell et al., 1986; Safa et al.,
1986), has an ATPase activity (Hamada & Tsuruo, 1988),
could act as a pump molecule (Gerlach et al., 1986; Gros et
al., 1986; Chen et al., 1986), and transport antitumour agents
outside the cells. It has been proposed that MDR modulators
such as verapamil and trifluoperazine act by competitive
inhibition of drug binding to P-glycoprotein on the plasma
membrane (Cornwell et al., 1986; Naito et al., 1988) and
subsequent blocking of drug efflux from the cell. Thus, in
order to identify if P-glycoprotein is involved in the cross-
resistance to a drug, it is a good tool to examine the effect of
such drug on the binding of 3H-daunomycin or3H-vincristine
to plasma membrane fraction isolated from MDR cells which
contain P-glycoprotein.
Isoquinolinesulfonamide derivatives, which were synthesis-
ed and characterised by Hidaka and coworkers (1984), inhibit
several protein kinases to a different extent. N-[2-(methyl-
amino) ethyl]-5-isoquinolinesulfonamide (H-8) has the high-
est affinity to cyclic nucleotide dependent protein kinases and
inhibits these enzyme activities effectively. 1-(5-Isoquinoline-
sulfonyl)-2-methylpiperazine, referred to H-7 is the most
potent inhibitor of Ca2+-phospholipid-dependent protein kin-
ase (protein kinase C) among the derivatives tested. In the
process of screening to identify drugs which reverse MDR,
we tested isoquinolinesulfonamide derivatives and found that
H-8 itself inhibited the growth of drug-sensitive parental cells
whereas MDR cells were very resistant to the growth-inhibi-
tory effect of H-8. In contrast to H-8, H-7 inhibited the
growth of both drug-sensitive and resistant P388 cells. To
determine if the resistance to H-8 observed in MDR P388
cells could be due to an overexpression ofP-glycoprotein and
a decreased accumulation of H-8, we assessed the effect of
H-8 on the binding of 3H-vincristine to membrane fraction
isolated from P388/VCR-600 cells and on the enhancement
of sensitivity to anti-tumour drugs in MDR cells. Our results
show that H-8 does not have any effect on these reactions,
suggesting that the resistance to H-8 is mediated through a
mechanism different from an overexpression of P-glyco-
protein.
Materials and methods
Chemicals
Vincristine sulfate was purchased from Shionogi Ltd, Osaka,
Japan and dissolved with methanol acidified with sulfuric
acid at pH 4.3. Adriamycin was purchased from Kyowa
Hakko Ltd, Tokyo, Japan. 4'-Demethylepipodophyllotoxin-
9-(4,6-O-ethylidene)-p-D-glucopyranoside (VP-16) was pur-
chased from Bristol Myers. H-7 and H-8 were purchased
from Seikagaku Kogyo, Tokyo, Japan and dissolved with
distilled water and stored at 4C at the concentration of
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10 mM. All these drugs were sterilised through a 0.2ftm
Corning filter. Adenosine 3':5'-cyclic monophosphate (cAMP),
guanosine 3':5'-cyclic monophosphate (cGMP), Kemptide
(Maller et al., 1978) were purchased from Sigma. 3H(-G)-
vincristine (7.4 Ci mM '), '25I-labelled F(ab')2 fragment of
sheep anti-mouse IgG, and [j-32P]ATP (3,000 Cimmol1')
were purchased from Amersham. C219 monoclonal antibody
was kindly provided from Dr V. Ling (Ontario Cancer
Research Institute, Toronto, Canada).
Cell lines and chemosensitivity
P388/VCR cells developed as described previously (Ido et al.,
1986). P388/VCR was maintained in humidified atmosphere
of 5% CO2 and 95% air in RPMI-1640 medium supplement-
ed with 10% foetal bovine serum and 20pM 2-mercapto-
ethanol (growth medium) without vincristine. P388/VCR was
stable for more than 2 years. P388/VCR-600 was developed
by treating P388/VCR cells with increasing concentration of
vincrinstine and now this cell line is about 200-times resistant
to vincristine and maintained with an intermittent exposure
to 400 nM vincristine. The growth-inhibitory effect of drugs
was assessed as described previously (Ido et al., 1987).
Cytosol andplasma membrane preparation
The procedure for isolation of plasma membrane from P388/
VCR-600 cells is as follows. Cells were harvested at logarith-
mic growth phase and washed three times with phosphate-
buffered saline (0.8% NaCl/0.115% Na2HPO4/0.02% KH2
P04/0.02% KCI) (PBS). All subsequent steps were carried
out at 4°C. The cells were resuspended in lysis buffer (50 mM
Hepes, pH 7.5/4 mM EDTA/2 mM EGTA/10% ethylene gly-
col/0.25 M sucrose/I mM dithiothreitol/0.2 mM phenylmethyl-
sulfonyl fluoride/l sg ml-I leupeptin) to a concentration of
about 1 x 10' cells per ml and homogenised with 3,000 r.p.m.
5 min using a motor-driven teflon-glass homogeniser. Cell
homogenate was centrifuged at 4,000g for 10 min. The
supernatant was centrifuged at 100,000g for 60 min. The
supernatant was used as cytol and the pellet was either
resuspended in a 0.1% Triton X-100 in lysis buffer or resus-
pended in 16% sucrose in 5 mM Tris-HCl, pH 7.5, overlaid
on 32% sucrose in 5 mM Tris-HCl, pH 7.5, and centrifuged
at 100,000g for 60 min. The membrane fraction at the inter-
face between 16 and 32% sucrose was used as a membrane
fraction. Protein concentration was determined with Bio-Rad
protein assay system.
Western blotting
Sodium dodesyl sulfate (SDS)-polyacrylamide gel electropho-
resis was performed according to slight modification of the
method of Laemmli et al. (1970). Protein profiles were
electroblotted onto nitrocellulose filter paper. The method
used was essentially that of Towbin et al. (1979). Blots were
probed with C219 monoclonal antibody against P-glycopro-
tein, overlaid with 125I-labelled F(ab')2 sheep anti-mouse IgG,
and binding was visualised by autoradiography.
Clonogenic assay
Cells were prepared as described above, treated with various
concentrations of H-8 for 72 h, after which cell suspension
was more than 500 times diluted with growth medium with
1% methylcellulose and plated. The number of cells plated
was adjusted to obtain approximately 200 colonies in the
dish (Lux 5221) without H-8. After incubation for 1 week,
colonies were counted using an inverted microscopy and the
surviving fractions were calculated by dividing the number of
colonies on the treated plates with the number ofcolonies on
the untreated control plates.
Cytokinetics
For cytokinetic measurement, cells were incubated with or
without 60tiM H-8 for 48 h and washed twice with PBS, at
which time cells were fixed with ethanol and processed as
before (Higashigawa et al., 1989) by staining with a propi-
dium iodide/RNAase and analysed on a Coulter EPICS-C
flow cytometer.
Binding assay
Binding of 3H-vincristine to membrane fraction was measur-
ed by filtration assay (Naito et al., 1988). Plasma membrane
fraction containing 20gg of protein was incubated at 37°C
with 100 nM 3H-vincristine and 3.3 mM ATP in 10 mM Tris-
HCI (pH 7.5), 250 mM sucrose, and 5 mM MgCl2 with or
without modifiers in a total volume of 100 JAl. After 60min
incubation, samples were collected and washed on glass fibre
filter (LM1I1-10, Labo Science Co. Ltd, Japan) with iced
PBS. The filters were dried and the radioactivity on each
membrane filter was measured in a liquid scintillation
counter.
Kinase assay
Cytosol and extracted membrane fraction were prepared as
described above and used as enzyme solution. A-kinase
activity and an inhibitory effect of H-8 were examined in a
50 gl of reaction mixture containing 50 mM morpholinopro-
panesulfonic acid (pH 7.0), 10 mM MgCl2, 0.25 mg ml-'
bovine serum albumin, 100 mM Kemptide, 10 mM [y32P]ATP
(300-600 c.p.m. pmol-'), enzyme, and 10IM cAMP with or
without various concentrations of H-8. The reactions are
initiated by the addition of ATP. Following incubation for
5 min at 30°C, the reaction was terminated by the addition of
100 ly 37.5% trichloacetic acid and processed as described
(Roskoski, 1983). G-kinase activity was assayed as described
(Inagaki et al., 1985).
Results
Resistance to anticancer drugs
Table I shows the sensitivity of P388, P388/VCR, and P388/
VCR-600 cells for vincristine, adriamycin, and VP-16. In
comparison with the parental P388 cells, P388/VCR and
P388/VCR-600 cells were 14.3 and 289.6-fold resistant to
vincristine, respectively. These two cell lines showed cross-
resistance to adriamycin and VP-16 according to their extent
of resistance to vincristine.
Western blotting
The expression of P-glycoprotein was examined in these cell
lines to evaluate the mechanism of MDR phenotype. Mem-
brane extracts from P388 cells, P388/VCR and P388/VCR-
600 were electrophoresed on 7.5% SDS-polyacrylamide gels,
and transblotted onto nitrocellulose membrane and reacted
with C219 monoclonal antibody followed by the reaction
with "25I-labelled F(ab')2 fraction of sheep antimouse IgG and
visualised by autoradiography. As shown in Figure 1, over-
expression of 170 kDa protein was observed in P388/VCR
and P388/VCR-600.
Effect ofisoquinolinesulfonamideprotein kinase inhibitors on
theproliferation ofcells
The effect of H-7 and H-8 on the proliferation of P388 cells,
P388/VCR and P388/VCR-600 was assessed by measuring
the number of cells per well, colony-forming capacity, and
DNA histograms following 48 h exposure to H-7 or H-8. As
shown in Figure 2a, H-8 dose-dependently inhibited the
growth of P388 cell line, however, P388/VCR-600 cell was
quite resistant to H-8 up to 200tLM. There was a significantCROSS-RESISTANCE TO A PROTEIN KINASE INHIBITOR H-8 IN MDR P388 CELL
Table I Sensitivity of P388, P388/VCR, and P388/VCR-600 cells to anticancer
drugs
IC50 (nM) (Degree ofresistanceb)
Drug P388a P388/VCRa P388/VCR-600a
Vincristine 2.25± 1.13 32.17±8.40 (14.3) 651.5±216.4 (289.6)
n=7 n=7 n=5
Adriamycin 68.6± 17.4 2545±1014.1 (37.2) 61393±33695 (896.2)
n=4 n=4 n=4
Etoposide 131.3±111.1 3528.8± 3482.6 (26.9) 36572.5± 15339.3 (278.5)
n=4 n=4 n=4
aDiluted to a density of 1-2 x 105 cellsml-, were exposed to drugs for 48 h and
then counted. bCalculated by dividing the IC50 value ofP388/VCR or P388/VCR-600
cells by that of P388 cells.
difference in the sensitivity of these cell lines to H-8 over
30 LM at P<0.05. By contrast, H-7 dose-dependently inhib-
ited the growth of these cell lines and there was no significant
difference in the sensitivity to growth inhibitory effect of H-7
among these cell lines (Figure 2b).
To determine whether the growth inhibition by H-8 may
be due to a killing of cells or an inhibition of cell cycle
progression, exponentially growing P388 cells, P388/VCR
and P388/VCR-600 cells were treated with various concentra-
tion of H-8 for 48 h and harvested and evaluated for cell
survival by colony formation or evaluated for the total
number of GO/GI, S, or G2/M phases determined by staining
cellular DNA with propidium iodide. Essentially no inhibi-
tion of colony formation was observed even in the drug-
sensitive P388 cells except for higher concentration of H-8.
Furthermore treatment of P388 cells with 60fAM of H-8
resulted in a decrease in S phase and an increase in GI and
G2 phase (Table II). By contrast, essentially no effect was
observed in the profile of DNA histogram when P388/VCR-
600 was treated with H-8. Thus the growth-inhibition by H-8
of P388 cells is mediated through the inhibition of cell cycle
progression at GI and G2 phase rather than through a killing
of cells.
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Figure 1 Western blot analysis of P388, P388/VCR, and P388/
VCR-600 cells. Plasma membrane extracts (30 jg) isolated from
above cell lines were electrophoresed on 7.5% sodium dodesyl
sulfate polyacrylamide gel and electroblotted onto nitrocellulose
membrane and reacted with C219 monoclonal antibody specific
for P-glycoprotein, followed by the reaction with F(ab')2 fraction
of '25I-labelled sheep antimouse IgG and visualised with auto-
radiography. Lane 1: P388; Lane 2: P388/VCR; Lane 3: P388/
VCR-600.
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Figure 2 The effect of H-8 a, and H-7 b, on the proliferation of
P388 (0), P388/VCR (A), and P388/VCR-600 (0). Cells were
incubated with or without drugs for 48 h and viable cell number
per well was counted. Points are mean ±s.d. from triplicate deter-
mination of representative experiment. Three more experiments
gave rise to the same results.
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Table II The effect of H-8 on cell cycle
Cell lines
P388 P388/VCR P388/VCR-600
GO/G, (%) 26.64 31.62 31.89
S (%) 50.12 49.20 33.05
Control G2/M (%) 23.22 19.16 33.04 CV (%) 3.80 3.81 4.27
GO/GI (%) 40.40 34.47 32.32
Treatment S (%) 25.41 40.58 39.61
with 60gM G2/M (%) 31.17 29.94 28.06
H-8 CV(%) 7.40 5.11 4.04
P388,P388/VCR,andP388/VCR-600cellsweretreatedwith60gMof
H-8 for 48 h, washed twice with phosphate-buffered saline, fixed with
ethanol, stained with propidium iodide, and analysed on Coulter
EPICS-C flow cytometer.
The effect ofH-8 on the binding of3H-vincristine to membrane
vesicles
Since P388/VCR and P388/VCR-600 overexpress P-glycopro-
tein which acts as a pump molecule and transports anticancer
agents outside the cell, we initially predicted that P-glyco-
protein should play an important role in the mechanism of
cross-resistance to H-8. These predictions were tested by
examining the effect of H-8 on the binding of 3H-vincristine
to membrane fractions isolated from P388/VCR-600 cells. As
shown in Figure 3, the binding of 3H-vincristine to mem-
brane fraction is inhibited in a dose-dependent manner by
vincristine, adriamycin, or verapamil whereas H-8 had no
effect at the concentration up to 100 riM.
A-kinase and G-kinase activities
To determine if the cross-resistance to H-8 observed in P388/
VCR-600 cell is due to an increase in A-kinase or G-kinase
activity, the enzyme activity of cytosol and membrane frac-
tion from P388 and P388/VCR-600 cell lines was measured.
Although A-kinase activity significantly increased in P388/
VCR-600 cells (Table III), H-8 inhibited A-kinase activity of
P388 and P388/VCR-600 cells in a similar rate (Figure 4).
There was no detectable G-kinase activity in these cell lines.
Discussion
Our data indicate that the growth of P388 cells, P388/VCR
and P388/VCR-600 is uniformly inhibited by H-7 and there
is no difference in the sensitivity to H-7 among these cell
lines. However there is a significant difference in the sen-
sitivity of cell lines to H-8. The growth of parental P388 is
dose-dependently inhibited by H-8. However MDR cell lines
Table III Distribution of A-kinase activity between cytosolic and
membrane fractions
Number A-kinase activity
of (pmolmin ' mg-Iprotein)a
Cell line experiment Cytosol Membrane Total
P388 3 78.9±7.54 376.4±59.3 455.3±66.0
P388/VCR-600 3 147.1±44.2 657.0± 18.0 804.1 ±48.2
P valueb NSC P<0.025 P<0.025
aMean±s.d.;bF-test;CNS, not significantly different. A-kinase assay
wasdone asdescribed in Materials and methods andexpressed aspmol
32P incorporated into Kemptide in 5 min at 30C in the presence or
absence of 10iLM cyclic AMP. In calculating A-kinase activity, cAMP-
independent activity was subtracted from cAMP-dependent activity.
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Figure 4 An inhibitory effect of H-8 on cyclic AMP-dependent
phosphorylation of Kemptide by cytosol (=II) and membrane
( - ) fraction of P388 a, and those of P388/VCR-600 cells b.
Concentrations causing 50% inhibition of A-kinase activities
from P388 cytosol, P388 membrane, P388/VCR-600 cytosol, and
P388/VCR-600 membrane are 3.37gM, 3.46gM, 2.19gM and
2.81 ytM respectively. Mean±s.d. of the triplicate determinations
from a representative experiment. One more experiment showed
same results. An absence of bar indicates the s.d. within the
symbol.
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FIgure 3 Inhibition of 3H-vincristine binding to plasma mem-
brane fractions isolated from P388/VCR-600 cells by H-8 (@),
adriamycin (0), vincristine (0), or verapamil (A). Mean±s.d.
of the triplicate determinations from a representative experiment.
One more experiment showed same results. An absence of bar
indicates the s.d. within the symbol.
showed resistance to H-8 according to their extent of resis-
tance to vincristine, adriamycin, and VP-16. One possible
explanation for the cross-resistance to H-8 might be related
to an overexpression of P-glycoprotein and the increased
efflux of H-8. Ifthis were the case for cross-resistance to H-8,
then P388/VCR and P388/VCR-600 would also show cross-
resistance to H-7, because H-7 and H-8 belong to isoquino-
linesulfonamide derivatives and have quite similar structures
(Hidaka et al., 1984). However we could not see any differ-
ence in the growth-inhibitory effect of H-7 among these cell
lines. Furthermore, H-8 had no effect to inhibit the binding
of 3H-vincristine to the membrane fractions isolated from
P388/VCR-600 cells. Moreover, H-8 neither enhanced the
accumulation of 3H-vincristine in P388/VCR-600 cells as
examined by whole cell assay (data not shown), nor increased
the sensitivity of P388/VCR-600 cells to vincristine and
daunomycin (data not shown). These data suggest that the
cross-resistance to H-8 observed in MDR P388 cell lines may
be most probably mediated through a mechanism different
from an overexpression of P-glycoprotein.
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Because the degree of resistance to H-8 is directly propor-
tional to both the intensity of resistance to anticancer drugs
such as vincristine, adriamycin, and VP-16 and the extent of
P-glycoprotein expression, the mechanism of resistance to
H-8 might be related to an amplification of a gene, the
overexpression of which might be the result of its co-ampli-
fication with mdr (P-glycoprotein) gene.
H-7 and H-8 inhibit several protein kinases in a different
extent. H-8 is reported to be the most potent inhibitor of
cyclic nucleotide-dependent protein kinases and inhibits pro-
tein kinase C more weakly than H-7 and vice versa. We
measured these kinase activities in these cell lines. Although
A-kinase activity was about 1.77-fold higher in P388/VCR-
600 cells than that in P388 cells, H-8 inhibited A-kinase
activity or both cell lines in a similar rate. No detectable
G-kinase activity was found in these cell lines. Therefore
cross-resistance to H-8 may not be related to a change in
A-kinase or G-kinase activity. Another explanation of this
phenomenon is that H-8 may affect one or more targets
unrelated to these protein kinases which could control regu-
latory pathways critical for the proliferation of the parental
P388 cells but not for that of P388/VCR-600 cells.
From the data present here, it is tentatively concluded that
the cross-resistance to H-8 observed in MDR variants of
P388 cells is not due to an overexpression of P-glycoprotein
or a change in A-kinase or G-kinase activity. Further studies
are necessary to identify the cause of the resistance to H-8 in
MDR cell lines.
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